SCHEMBL24101511

SCHEMBL24101511

CN(C)[C@@H]1CCc2[nH]c3cnccc3c2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.45
HTR1D P28221 6/20 0.45
HTR1B P28222 5/20 0.45
NR2E1 Q9Y466 1/20 0.40
CHRM3 P20309 2/20 0.37
CHUK O15111 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
IKBKB O14920 1/20 0.36
AURKA O14965 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PIM1 P11309 1/20 0.36
TOP1 P11387 1/20 0.36
GABRA1 P14867 1/20 0.36
IDO1 P14902 1/20 0.36
HPGD P15428 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24101523 1.00 HTR1F (0.45) HTR1FHTR1DHTR1BNR2E1CHRM3
SCHEMBL25847146 1.00 HTR1F (0.45) HTR1FHTR1DHTR1BNR2E1CHRM3
SCHEMBL24101498 0.92 HTR1D (0.40) HTR1FHTR1DHTR1BNR2E1CHUK
SCHEMBL24101860 0.92 HTR1D (0.40) HTR1FHTR1DHTR1BNR2E1CHUK
SCHEMBL24101500 0.92 HTR1D (0.40) HTR1FHTR1DHTR1BNR2E1CHUK
SCHEMBL24101864 0.89 HTR1F (0.47) HTR1FHTR1DHTR1BNR2E1CHRM3
SCHEMBL24101538 0.89 HTR1F (0.47) HTR1FHTR1DHTR1BNR2E1CHRM3
SCHEMBL24101526 0.89 HTR1F (0.47) HTR1FHTR1DHTR1BNR2E1CHRM3
SCHEMBL24101508 0.87 CHUK (0.39) HTR1DHTR1BCHUKKDM4EGABRP
SCHEMBL24101496 0.87 CHUK (0.39) HTR1DHTR1BCHUKKDM4EGABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-20 US disclosed
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-20 US disclosed
WO-2021252691-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF GAP43, GRIN2A, GRIN2C HTR1F 149/4885HTR1D 79/4885HTR1B 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.